Sourasky Medical Center (Ichilov)
Standard Hepatitis C treatment in Israel follows a universal access model using Direct-Acting Antiviral (DAA) medications. These oral therapies replace interferon-based protocols and achieve success rates exceeding 95%. Leading specialists like Dr. Rafael Bruck at Sourasky Medical Center manage these 8-to-12-week regimens.
Bookimed Expert Insight: While public health covers citizens, international patients often choose Tel Aviv for its high concentration of liver experts. Dr. Oren Shebolet at Sourasky Medical Center manages complex cases that failed previous DAA attempts. The 90% oncology success rate at this facility reflects the high standard for all hepatological conditions.
Patient Consensus: Patients note it is vital to finalize insurance or residency status quickly to access subsidized medication. Many emphasize that starting treatment early avoids long-term liver damage and improves daily energy levels.
Israel operates a formal National Program for Hepatitis C Elimination launched in 2021. This initiative provides universal access to direct-acting antiviral medications for all citizens. It utilizes targeted screening and simplified diagnostics to meet World Health Organization goals by 2030.
Bookimed Expert Insight: While national programs focus on public health, private facilities like Sourasky Medical Center offer specialized expertise for complex cases. Doctors like Dr. Oren Shebolet and Prof. Rafael Bruck have over 40+ years of experience. This high level of specialization at a center treating 1,800,000 patients annually ensures access to refined clinical schemes for chronic infections.
Patient Consensus: Patients emphasize that treatment through health funds is exceptionally fast. Many note that fibrosis stage rarely blocks access to these highly effective cures.
Israeli hospitals manage Hepatitis B through advanced diagnostic protocols and antiviral therapies aligned with European Association for the Study of the Liver (EASL) guidelines. Specialists use non-invasive Fibroscan imaging and ultrasound-guided biopsies to assess liver health and initiate targeted pharmacological treatment.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of academic integration in hepatology. Experts like Dr. Oren Shibolet at Sourasky Medical Center hold memberships in both American and European liver associations. This ensures patients receive treatment protocols that are updated in real-time with global research. For international patients, this means access to medications like TAF or TDF often faster than in other regions.
Patient Consensus: Patients report that while administrative paperwork can be time-consuming, the speed of diagnosis is impressive. Many note that doctors quickly start antiviral treatment and emphasize regular six-month monitoring to prevent complications.
Leading Israeli medical centers for viral hepatitis include Sourasky Medical Center, Rambam Medical Center, and Shaare Zedek. These JCI-accredited institutions utilize advanced elastography and antiviral protocols. Specialized hepatologists like Dr. Oren Shebolet and Prof. Rafael Bruck lead comprehensive programs for Hepatitis B and C.
Bookimed Expert Insight: Data shows a high concentration of expertise at Sourasky Medical Center in Tel Aviv. Dr. Oren Shebolet and Prof. Rafael Bruck bring 90+ years of combined experience. This depth of seniority is rare. It ensures patients receive protocols refined over decades of clinical practice.
Patient Consensus: Patients value the availability of innovative clinical trials and direct access to English-speaking staff. Many note that bringing previous lab results significantly speeds up the diagnostic process.
Diagnostic protocols in Israel for viral hepatitis involve serological screening and molecular PCR testing to measure viral load. Facilities like Sourasky Medical Center (Ichilov) use advanced DNA and RNA sequencing to identify genotypes. This ensures targeted antiviral therapy and precise monitoring of treatment response.
Bookimed Expert Insight: While many patients focus on initial viral detection, the presence of specialists like Prof. Rafael Bruck, who has over 40 years of experience, highlights the importance of longitudinal monitoring. In large multidisciplinary centers like Sourasky, which serves 400,000+ patients annually, the integration of radioisotope research and metabolic assessments provides a deeper look at liver health than standard blood panels alone.
Patient Consensus: Patients emphasize requesting a FibroScan early to avoid invasive biopsies and establish a baseline. They also note that getting genotype results quickly is vital for starting the correct treatment without delays.
International travelers can obtain Hepatitis A and B vaccinations at specialized clinics throughout Israel. Services are available in major cities like Jerusalem, Tel Aviv, and Haifa. Specialized traveler clinics and hospital departments like those at Sourasky Medical Center provide these vaccines to tourists and students.
Bookimed Expert Insight: While many travelers seek large hospitals, private centers like Ramat Aviv Medical Center often provide faster access for diagnostics. Sourasky Medical Center serves 1,800,000 patients annually and is ranked in the top 10 globally. This high volume across Israeli clinics ensures that medical staff are highly experienced with international vaccination protocols and multi-dose scheduling for travelers.
Patient Consensus: Patients find it helpful to use pharmacies like Super-Pharm for quick access to Hepatitis A shots. Bringing a passport and insurance documents is essential for a smooth experience at these clinics.
Hepatitis C treatment in Israel achieves success rates between 95% and 98.8% using advanced direct-acting antiviral agents. These oral medications target the virus directly over 8 to 12 weeks. Clinical programs at JCI-accredited facilities confirm high cure rates across all genotypes and patient demographics.
Bookimed Expert Insight: While Israel offers universal access to medication for residents, international patients benefit from the high-volume expertise at centres like Sourasky Medical Center. It treats over 400,000 patients annually. This massive scale allows gastroenterologists to refine protocols for complex cases involving liver cirrhosis or metabolic disorders.
Patient Consensus: Modern tablets are much easier to tolerate than older injections. Patients highlight that while symptoms improve quickly, the final blood test is the only way to confirm the virus is gone. In Israel, specialists use PCR tests and elastography scans to monitor liver health throughout the process.
Israeli medical centres manage chronic Hepatitis B effectively through advanced antiviral therapies and non-invasive liver monitoring. Specialists like Dr Oren Shebolet at Sourasky Medical Center follow international EASL guidelines. These facilities focus on suppressing viral replication to protect liver function and prevent long-term progressive scarring.
Bookimed Expert Insight: Israeli specialists are uniquely skilled with the precore mutant strain common in the region. This virus type requires more frequent monitoring than standard cases. At Sourasky Medical Center, heads of units often have over 40 years of experience, providing a higher level of case intuition for patients with fluctuating viral loads.
Patient Consensus: Patients in Israel emphasize that treatment focuses on long-term virus suppression and liver protection. They note it is essential to bring all previous viral load tests and scans from home to help specialists make faster decisions during the initial consultation.
Advanced non-invasive imaging and biomarker panels have largely replaced traditional liver biopsies in Israel. Leading centres like Sourasky Medical Center (Ichilov) and Rambam Medical Center use FibroScan elastography, MRI-based mapping, and machine-learning algorithms. These tools provide precise staging for chronic hepatitis cases.
Bookimed Expert Insight: Israeli hepatology units stand out because they integrate radioisotope research and AI-driven diagnostics into routine care. Specialists like Prof. Rafael Bruck and Dr Oren Shebolet at Sourasky Medical Center leverage over 40 years of experience with these technologies. This deep expertise often leads to faster staging compared to standard gastroenterology clinics.
Patient Consensus: Patients in Israel note that FibroScan is the practical choice for routine monitoring. They find that specialist hepatologists provide more cohesive monitoring plans than generalists.
Secondary procedures manage life-threatening complications when medical therapies fail. Israeli hospitals offer interventions for fluid buildup, internal bleeding, and organ failure. Specialists like Dr Oren Shebolet use shunts, endoscopic banding, and liver dialysis. These procedures bridge the gap to a definitive liver transplant.
Bookimed Expert Insight: Israeli liver units provide an advantage through high-volume multidisciplinary care. For example, Sourasky Medical Center serves over 1,800,000 patients annually. Experienced specialists like Prof. Dr Rafael Bruck, with over 40 years of experience, manage complex viral hepatitis cases. This scale allows for rapid access to sub-specialised shunt embolisation and advanced liver dialysis technologies.
Patient Consensus: Patients note that procedures like endoscopic banding are vital for preventing bleeding. They emphasise that while antiviral drugs slow damage, procedures like TIPS are necessary bridges to transplant. Australian patients often highlight the value of combined diagnostic imaging and drainage when managing advanced cirrhosis in Israel.
Israeli medical centres manage Hepatitis B and C as primary clinical priorities. Specialist units at Sourasky Medical Center and Rambam Medical Center use advanced antiviral protocols. Clinicians also treat Hepatitis D co-infections and acute cases of Hepatitis A and E with expert supportive care.
Bookimed Expert Insight: Israeli hepatology units stand out because their leads often hold dual specialisations. Dr Rafael Bruck at Sourasky Medical Center has over 40 years of experience in both hepatology and oncology. This combined expertise is vital for patients with chronic hepatitis who require long-term monitoring for liver cancer.
Patient Consensus: Patients find that care in Israel is structured around comprehensive specialist-led management rather than simple procedures. They recommend coordinating follow-up blood work with Australian GPs before travelling to ensure seamless long-term monitoring.